Recent advances in co-amorphous drug formulations

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Recent advances in co-amorphous drug formulations. / Dengale, Swapnil Jayant; Grohganz, Holger; Rades, Thomas; Löbmann, Korbinian.

In: Advanced Drug Delivery Reviews, Vol. 100, 01.05.2016, p. 116-125.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Dengale, SJ, Grohganz, H, Rades, T & Löbmann, K 2016, 'Recent advances in co-amorphous drug formulations', Advanced Drug Delivery Reviews, vol. 100, pp. 116-125. https://doi.org/10.1016/j.addr.2015.12.009

APA

Dengale, S. J., Grohganz, H., Rades, T., & Löbmann, K. (2016). Recent advances in co-amorphous drug formulations. Advanced Drug Delivery Reviews, 100, 116-125. https://doi.org/10.1016/j.addr.2015.12.009

Vancouver

Dengale SJ, Grohganz H, Rades T, Löbmann K. Recent advances in co-amorphous drug formulations. Advanced Drug Delivery Reviews. 2016 May 1;100:116-125. https://doi.org/10.1016/j.addr.2015.12.009

Author

Dengale, Swapnil Jayant ; Grohganz, Holger ; Rades, Thomas ; Löbmann, Korbinian. / Recent advances in co-amorphous drug formulations. In: Advanced Drug Delivery Reviews. 2016 ; Vol. 100. pp. 116-125.

Bibtex

@article{d9ac6219afb8404993c966df8e7161ee,
title = "Recent advances in co-amorphous drug formulations",
abstract = "Co-amorphous drug delivery systems have recently gained considerable interest in the pharmaceutical field because of their potential to improve oral bioavailability of poorly water-soluble drugs through drug dissolution enhancement as a result of the amorphous nature of the material. A co-amorphous system is characterized by the use of only low molecular weight components that are mixed into a homogeneous single-phase co-amorphous blend. The use of only low molecular weight co-formers makes this approach very attractive, as the amount of amorphous stabilizer can be significantly reduced compared with other amorphous stabilization techniques. Because of this, several research groups started to investigate the co-amorphous formulation approach, resulting in an increasing amount of scientific publications over the last few years. This study provides an overview of the co-amorphous field and its recent findings. In particular, we investigate co-amorphous formulations from the viewpoint of solid dispersions, describe their formation and mechanism of stabilization, study their impact on dissolution and in vivo performance and briefly outline the future potentials.",
author = "Dengale, {Swapnil Jayant} and Holger Grohganz and Thomas Rades and Korbinian L{\"o}bmann",
year = "2016",
month = may,
day = "1",
doi = "10.1016/j.addr.2015.12.009",
language = "English",
volume = "100",
pages = "116--125",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Recent advances in co-amorphous drug formulations

AU - Dengale, Swapnil Jayant

AU - Grohganz, Holger

AU - Rades, Thomas

AU - Löbmann, Korbinian

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Co-amorphous drug delivery systems have recently gained considerable interest in the pharmaceutical field because of their potential to improve oral bioavailability of poorly water-soluble drugs through drug dissolution enhancement as a result of the amorphous nature of the material. A co-amorphous system is characterized by the use of only low molecular weight components that are mixed into a homogeneous single-phase co-amorphous blend. The use of only low molecular weight co-formers makes this approach very attractive, as the amount of amorphous stabilizer can be significantly reduced compared with other amorphous stabilization techniques. Because of this, several research groups started to investigate the co-amorphous formulation approach, resulting in an increasing amount of scientific publications over the last few years. This study provides an overview of the co-amorphous field and its recent findings. In particular, we investigate co-amorphous formulations from the viewpoint of solid dispersions, describe their formation and mechanism of stabilization, study their impact on dissolution and in vivo performance and briefly outline the future potentials.

AB - Co-amorphous drug delivery systems have recently gained considerable interest in the pharmaceutical field because of their potential to improve oral bioavailability of poorly water-soluble drugs through drug dissolution enhancement as a result of the amorphous nature of the material. A co-amorphous system is characterized by the use of only low molecular weight components that are mixed into a homogeneous single-phase co-amorphous blend. The use of only low molecular weight co-formers makes this approach very attractive, as the amount of amorphous stabilizer can be significantly reduced compared with other amorphous stabilization techniques. Because of this, several research groups started to investigate the co-amorphous formulation approach, resulting in an increasing amount of scientific publications over the last few years. This study provides an overview of the co-amorphous field and its recent findings. In particular, we investigate co-amorphous formulations from the viewpoint of solid dispersions, describe their formation and mechanism of stabilization, study their impact on dissolution and in vivo performance and briefly outline the future potentials.

U2 - 10.1016/j.addr.2015.12.009

DO - 10.1016/j.addr.2015.12.009

M3 - Journal article

C2 - 26805787

VL - 100

SP - 116

EP - 125

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

ER -

ID: 162186428